Longboard Pharmaceuticals Inc (LBPH) PT Raised to $60 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts LBPH Hot Sheet
Price: $59.98 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Patrick Trucchio raised the price target on Longboard Pharmaceuticals Inc (NASDAQ: LBPH) to $60.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Banco del Bajio SA (BBAJIOO:MM) (BBAJF) to Neutral
- Natwest Group PLC (NWG:LN) (NWG) PT Lowered to GBP7.80 at Morgan Stanley
- JPMorgan Upgrades Gentera SAB de CV (GENTERA*:MM) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
